Ovarian carcinoma is the leading cause of death in female genital tract malignancies. Amplification and overexpression of the c-erbB-2 gene (Slamon et al.. 1989) . mutational activation of the K-ras gene (Fukumoto et al.. 1989) . and mutation of the p53 tumour-suppressor gene (Berchuck et al.. 1990 : Okamoto et al.. 1991 : Koshivama et al.. 1995 are detected in ovanran cancer. The nm23 gene was initially cloned as a metastasis-suppressor gene by differential hybnrdisation between low and high metastatic clones of a murine melanoma cell line (Steeg et al.. 1988) . Two isotypes. nm23-HI and nm23-H2. have been identified in the human genome (Stahl et al.. 1991) and expression levels of the nm23 genes are inversely correlated with metastatic potential in breast (Barnes et al.. 1991) . gastric (Nakayama et al.. 1993 ) and hepatic carcinomas (Nakavama et al.. 1992 ) and malignant melanomas (Florenes et al.. 1992) . We previously reported mRNA levels of the nm23 genes in ovarian tumour tissues; both nm23-HJ and nm23-H2 gene expressions are much higher in carcinomas than in benign tumours. Furthermore. expression of the nm23-HJ gene is significantly lowIer in carcinomas possessing ly-mph node and or distant metastases than those without metastasis (Mandai et al.. 1994) . However. it remains undetermined whether the changes in nm23 expression are associated with its genetic alterations or not.
Qualitative as well as quantitative alterations of the nm23 genes such as loss of heterozygosity (LOH) . amplification and point mutation have recently been reported in colon carcinoma (Cohn et al.. 1991 : Wang et al.. 1993 ) and in neuroblastoma (Hailat et al.. 1991 : Leone et al.. 1993 RNA preparation, cDNA synthesis, and SSCP anal vsis of PCR products ( PCR-SSCP) Isolation of total RNA. preparation of complementary DNA and PCR were carnred out according to the method previously described (Mandai et al., 1994) . The initial PCR amplified 3' and 5' halves of cDNAs of nm23-HJ (bases 81-356 and 319-586 respectively) and nm23-H2 (bases 53-330 and 293-632 respectively), as described by Leone et al. (1993) . Regions corresponding to exon 1 and exon 2 of the K-ras gene were amplified using a Ras gene primer set (Takara Shuzo, Kyoto. Japan). Fifteen cycles of second PCR were performed using 0.5 gl from the initial PCR im a mixture of 8 pmol per primer, 125 timol of dNTP other than dCTP, 12.5 pmol of dCTP, 37 kBq of [(-3-P] I1   II  II  III  III  II  HI  III  III  III  III  III  Ill  III  III  III  III   III  III  III   IV  IV  IV  IV Sequencing of the mutated nm23 genes The PCR product was subcloned into pUC18 plasmid, and six clones containing an insert were obtained. On SSCP analysis, three of the six clones exhibited the same mobility as the mutant allele previously detected and the remaining showed mobility of wild-type allele (Figure la Relationship between the nm23 mutation, LOH at the nm23 locus or K-ras mutation and expressions of the nm23 genes
The status of mutation of the nm23 genes, LOH at nm23 locus and K-ras gene mutation was analysed in relation to mRNA levels of the nm23-HI and the nm23-H2 genes which were determined in our previous study (Mandai et al., 1994) .
A case with nm23-H2 mutation showed low levels of expression for both nm23-H] and nm23-H2 ( Consequently, mutation of the nm23 genes is not a common feature of ovarian carcinoma and may not significantly contribute to its tumour progression. The mutation of the nm23-H2 gene found in the present study was located in codon 133, which resulted in amino acid change from Trp to Arg. This is different from that previously reported in a case of neuroblastoma (Leone et al., 1993) , in which the mutation was located in codon 48 of the nm23-H2 gene. An X-ray analysis for the structure of NDP kinase of a slime mould suggests that Trp-133 in human NDP kinase donates an H-bond to His-51 near the active site (Morera et al., 1994) . Although both conserved among Drosophila and vertebrates, they may not be implicated in kinase activity (Morera et al., 1994) . Thus, the mutation found in this study could be a random event which does not affect biological activity of NDP kinase. However, a mutation of the NDP kinase gene in Drosophila causes lower stability without changes of kinase activity resulting in altered interactions between NDP kinase and other proteins (Lascu et al., 1992) , and biological relevance of the mutation in this residue remains uncertain.
It is reported that the incidence of LOH at the nm23 locus is found in 65% of ovarian cancer and that allelic loss on chromosome 17q is higher in advanced stages of ovarian carcinoma than in the early stages (Phillips et al., 1993) . In Japan, ovarian carcinoma is less common than in other Western countries (Tashiro et al., 1992) and allelic loss on chromosome 17 of Japanese ovarian cancer (Sato et al., 1991) is about half as frequent compared with other studies (Jacobs et al., 1993; Phillips et al., 1993) . In the present study LOH at the nm23 locus was observed in 23.8% of informative cases. Tlhis suggests that genetic changes different from those found in Western countries may also contribute to ovarian carcinogenesis in Japan. Furthermore, it may be because informative cases in the current study were composed of a relatively high proportion of early stages (stage I and I) that the incidence of nm23 LOH was low. In colorectal carcinomas, LOH of the nm23-HI gene was reportedly associated with a more aggressive behaviour of the tumour (Cohn et al., 1991) . In the present study, however, the presence of LOH at the nm23 locus in ovarian carcinoma was not significantly correlated with its stage or metastatic status. As the number of cases investigated is limited, further study is necessary to verify the correlation between LOH at the nm23 locus and the tumour progression, and nm23 expression in ovarian carcinoma.
Mutation of the K-ras gene was found in 2 of the 35 (5.7%) ovarian carcinomas, and was localised in codon 12 and codon 13 respectively. The incidence and locations are consistent with previous reports on K-ras mutation in ovarian carcinomas (Fukumoto et al., 1989 , Enomoto et al., 1991 , indicating that cDNA preparation in the present study was adequate for analysis of expressed genes in tumour cells. The presence of K-ras mutation was not related with the stage or metastatic status of the tumour. In a case of stage III carcinomas, the sample from peritoneal metastasis showed the same mutation as that from the primary tumour.
This suggests that the cancer cells are monoclonal as well as that the mutation of the K-ras gene is a relatively early event during the progression of ovarian carcinoma. Interestingly, the expression levels of both the nm23-HI and the mn23-H2 genes were higher in the tumour with K-ras mutation compared with those without. We previously reported signficantly positive correlation between nm23-HI expression and c-erbB-2 expression in ovarian carcinoma (Mandai et al., 1994) . Since products of the nm23 genes have been thought to play an important role as modulators of biochemical pathways either through NDP kinase activity (Teng et al., 1991) or through other forms of phosphorylase activity (MacDonald et al., 1993) , there may be some relationship between K-ras mutation and increased expression of the rn23 genes in ovarian cancer cells. The current study suggests that mutation of the nm23 genes and the K-ras gene affects expression of the nm23 gene in ovarian carcinoma and is related to its carcinogenesis or progression.
Abbreviaioas LOH, loss of heterozygosity; PCR. polymerase chain reaction:
RT-PCR, reverse-transcription PCR; SSCP, single-strand conformational polymorphism; LMP. low malignant potential: NDP kinase. nucleoside disphosphate kinase.
